UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Everpar Advisors LLC

Everpar Advisors LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 38.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 808 shares of the healthcare conglomerate’s stock after selling 509 shares during the period. Everpar Advisors LLC’s holdings in UnitedHealth Group were worth $409,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. WINTON GROUP Ltd acquired a new position in UnitedHealth Group during the 2nd quarter worth approximately $228,000. Renaissance Technologies LLC purchased a new position in UnitedHealth Group in the second quarter valued at $36,323,000. Sienna Gestion boosted its position in shares of UnitedHealth Group by 2,619.2% during the 2nd quarter. Sienna Gestion now owns 21,074 shares of the healthcare conglomerate’s stock worth $10,727,000 after acquiring an additional 20,299 shares in the last quarter. First Eagle Investment Management LLC raised its position in shares of UnitedHealth Group by 963.5% during the 2nd quarter. First Eagle Investment Management LLC now owns 411,381 shares of the healthcare conglomerate’s stock worth $209,500,000 after acquiring an additional 372,701 shares in the last quarter. Finally, Miramar Capital LLC increased its stake in UnitedHealth Group by 7.5% in the second quarter. Miramar Capital LLC now owns 23,325 shares of the healthcare conglomerate’s stock valued at $11,878,000 after purchasing an additional 1,627 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $511.02 on Friday. The business has a fifty day moving average of $553.38 and a two-hundred day moving average of $562.98. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $470.28 billion, a P/E ratio of 33.29, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company posted $5.83 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on UNH shares. Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Barclays raised their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. Finally, UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.